ConductScience.org, home

Paper35865481

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.

Jiang D and 12 others. Front Oncol, 2022. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma. Papers, record 35865481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35865481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.
PubMed
Journal
Front Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2022-07-23
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang DDongxian
2Song QQi
3Wei XXiaojun
4Yu ZZixiang
5Liu YYufeng
6Wang HHaixing
7Wang XXingxing
8Huang JJie
9Su JJieakesu
10Hong YYang
11Xu YYifan
12Xu CChen
13Hou YYingyong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125214542The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.Ann Oncol2015https://conductscience.org/library/papers/25214542PubMed
230296523PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.Hum Pathol2019https://conductscience.org/library/papers/30296523PubMed
317044039Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.Prostate2007https://conductscience.org/library/papers/17044039PubMed
434419685Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC.J Thorac Oncol2021https://conductscience.org/library/papers/34419685PubMed
524614649Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.Eur J Cancer Prev2014https://conductscience.org/library/papers/24614649PubMed
632449246Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.Cancer Sci2020https://conductscience.org/library/papers/32449246PubMed
732937743Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.Int J Mol Sci2020https://conductscience.org/library/papers/32937743PubMed
833816285POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy.Front Oncol2021https://conductscience.org/library/papers/33816285PubMed
932736034Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.Drug Resist Updat2020https://conductscience.org/library/papers/32736034PubMed
1032060377Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma.Mod Pathol2020https://conductscience.org/library/papers/32060377PubMed
1133247565PMS2: a potential prognostic protein marker in oral squamous cell carcinoma.Med Oral Patol Oral Cir Bucal2021https://conductscience.org/library/papers/33247565PubMed
1217397816DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis.Clin Chim Acta2007https://conductscience.org/library/papers/17397816PubMed
1334218257PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma.Mod Pathol2021https://conductscience.org/library/papers/34218257PubMed
1426559582PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.N Engl J Med2015https://conductscience.org/library/papers/26559582PubMed
1534272092PD-L1 expression in tumor cells is associated with a favorable prognosis in patients with high-risk endometrial cancer.Gynecol Oncol2021https://conductscience.org/library/papers/34272092PubMed
1628522752Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis.Cancer Res2017https://conductscience.org/library/papers/28522752PubMed
1716231369Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.J Surg Oncol2005https://conductscience.org/library/papers/16231369PubMed
1826028255PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.N Engl J Med2015https://conductscience.org/library/papers/26028255PubMed
1934009410Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer.Cancer Immunol Immunother2022https://conductscience.org/library/papers/34009410PubMed
2031623180Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future.Int J Mol Sci2019https://conductscience.org/library/papers/31623180PubMed

See all 42 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42038015High PMS2 Expression-Based Nomogram for Risk Stratification in Resected Hepatocellular Carcinoma: Application to Recurrence and Neoadjuvant Therapy Selection.J Cancer2026https://conductscience.org/library/papers/42038015PubMed
40587482The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.PLoS One2025https://conductscience.org/library/papers/40587482PubMed
40416179Mismatch Repair Deficiency in Esophageal Squamous Cell Carcinoma: An Underrecognized Biomarker for Immunotherapy Response.Cureus2025https://conductscience.org/library/papers/40416179PubMed
38975889
Characteristics of auto-quantified tumor-infiltrating lymphocytes and the prognostic value in adenocarcinoma of the esophagogastric junction, gastric adenocarcinoma, and esophageal squamous cell carcinoma.
Aging (Albany NY)2024https://conductscience.org/library/papers/38975889PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35865481

GET https://conductscience.org/api/papers/v1/35865481/references?page=2